Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-My...(r revise the statementsmade herein or th...),Health

(Date:12/16/2009)... Access to Quality, Cost-Effective Care , ... Washington, D.C. ... debated the best ways to rein in runaway costs while providing ... important part of the ongoing discussion includes how to ensure patients ... doctors of medicine (MDs) or osteopathy (DOs). In both the ...

(Date:12/16/2009)... and Paper technology and the provider of the optimal paper-based ... is ranked among the Fastest Growing Technology Companies on the ... ... (PRWEB) December 16, 2009 -- Kayentis ... and management of handwritten data. Kayentis targets the Healthcare and ...

(Date:12/16/2009)... Age should not be determining factor for use, expert ... people with heart failure are much less likely to ... a new study. , The study included 4,685 people, ... device and had a left ventricular fraction (a measure ... less. , During a three-year period, those who were ...

(Date:12/16/2009)... Dec. 16 Shoppers like knowing if ... or Argentina. But grocers have found it burdensome ... (COOL) laws requiring them to provide the information ... at easyCOOLnow.com for easily making grocery ... include provisions that require retailers of unprocessed fruits, ...

(Date:12/16/2009)... software program developed by CareRise will reduce the time ... staffing needs as it relates to the patient population. ... to calculate their mandatory nurse-to-patient staffing needs, comply with ... report as to how it affects their bottom line. ... in the healthcare industry, has been allowed a United ...

... CIGNA HealthCare of Arizona and Catholic,Healthcare ... CIGNA plan,members will have in-network access to ... West facilities and providers. The contract covers,Catholic ... Joseph,s,Hospital and Medical Center, Chandler Regional Medical ...

... May 9 Almost Family, Inc.,(Nasdaq: AFAM ... nursing,services, today announced that the underwriter of the ... and purchased 262,500,additional shares of common stock at ... the over-allotment, the Company sold 2,512,500 shares,in the ...

... those who take up the habit , , FRIDAY, May 9 ... in their everyday conversations with peers helps reduce smoking rates, ... study included almost 11,000 students, ages 12 to 13, at ... the schools, certain students were selected to receive training about ...

... depression and many other diseases, researchers say , , ... class of drugs called vaptans may be able ... painful periods, brain hemorrhage, psychotic disorders and glaucoma, ... antagonists, work by targeting the vasopressin hormone system, ...

... Alseres,Pharmaceuticals, Inc. (Nasdaq: ALSE ), today ... Thursday, May 15th, 2008 at 9:00am EDT to ... discuss other matters related to,the Company., (Logo: ... conference call, please dial 877-795-3649 for domestic,and 719-325-4817 ...

... Passport Health, nationwide travel medicine providers and,disaster response ... with recovery efforts after Cyclone Nargis. Cholera has ... fresh water or food available. The flood-swollen,waterways that ... bodies,and animal carcasses. Vaccines for food and water ...

(Date:12/16/2009)... NASHVILLE, Tenn. , Dec. 16 ... medical cost management services, today commended two new ... from CT scans and other diagnostic imaging tests. ... essential to proper diagnosis and treatment," said Gregg ... these new studies offer more compelling evidence that ...

(Date:12/16/2009)... a national healthcare consulting firm, reported success this ... - the total amount of money that its ... more than a half-million patients nationwide by doing ... - in less than two years. ,, "We,re ... bottom lines and still were able to significantly ...

(Date:12/16/2009)... WORTH, Texas, Dec. 16 Wound ... a rapidly growing provider of specialty medical ... operating subsidiary is moving toward productization of ... The company currently anticipates products to be ... market, estimated to be a multi-billion dollar ...

... Mature Dendritic Cells -, WAYNE, N.J., June ... of a Phase II trial were,published in the ... Oncology. The,study showed that Leukine(R) (sargramostim) demonstrated a ... dendritic cells in high-risk,melanoma patients. Dendritic cells are ...

... PHILADELPHIA, June 30 ,GlaxoSmithKline (NYSE: GSK ) today ... Food and Drug Administration (FDA) for approval,of CERVARIX(R), its ... its response to questions raised by the FDA in ... given,that final data from GSK,s Phase III pivotal efficacy ...

Colloidal Gold Conjugated, Streptavidin - 50 OD...

Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 12 OD...

Colloidal Gold Conjugated, Goat anti-mouse IgG (H&L) - 50 OD...

Colloidal Gold Conjugated, Goat anti-human IgG (H&L) - 12 OD...